Sign in
4

Changes in Ownership

Nautilus Biotechnology, Inc. Filed Acc 0001808805-22-000101

Senior VP, Product Development bought 15,000 shares at an average $2.03 ($30,399)

From the SEC's structured data for this filing

Trades in this filing

Sankar Subramanian · Senior VP, Product Development

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-09-26 Purchase : show line 1 in the form +10,000 $2.03 $20,250 86,250 D
2022-09-27 Purchase : show line 2 in the form +5,000 $2.03 $10,149 91,250 D
Open-market purchases · 15,000 sh · avg $2.03 · $30,399
Loading xslF345X03/wf-form4_166439528878324.xml…